CORT
Corcept Therapeutics Incorporated · Healthcare
Chief Development Officer William Guyer sold $1.0M of Corcept Therapeutics Incorporated
Sold$1,036,600
$51.83Price
20,000Shares
−90%Stake
What CORT did after the filing
- The stock from Fri, May 8 open, $51.05
- +56.4%
- S&P 500, same days
- −0.2%
Measured over 30 trading days, to the Jun 23 close.
Traded Tue, May 5. Filed Thu, May 7, 4:30 PM ET, after the close. Returns use the May 8 open and the Jun 23 close. Not investment advice.